[Leish-l] Back to business

killickendrick killickendrick at wanadoo.fr
Tue Apr 7 14:54:21 BRT 2009


Jacques,
    You are right. If allopurinol is as good as Glucantime, it should be used universally. Can you give us references to trials that show this? if not, who will do a double blind trial and settle the question once and for all. Are there any other than Jacques who have an opinion for us?
Bob

Carlos,
    It may be forbidden in Brazil. But Glucantime is widely used in Europe in spite of the old Italian study showing the danger of selecting resistance. (By 'old Italian', I mean a study done some time ago - it is not a reference to the age of the workers who did the study. I would not want to offend my friend Luigi Gradoni!)
Bob
  ----- Original Message ----- 
  From: Carlos Brisola Marcondes 
  To: Jaclamothe at aol.com 
  Cc: leish-l at lineu.icb.usp.br 
  Sent: Tuesday, April 07, 2009 3:16 PM
  Subject: Re: [Leish-l] Back to business


  Dear all
     I would remind that the utilization for dogs of drugs utilized for humans was forbidden in the last year by federal government.
     Would it be viable to treat thousands of dogs in the huge (and variable) endemic area of Brazil, which are replaced very quickly? Would any of us like to have positive dogs being treated in our neighbourhood?

  Best wishes
  Carlos Brisola Marcondes----- Original Message ----- 
    From: Jaclamothe at aol.com 
    To: killickendrick at wanadoo.fr ; leish-l at lineu.icb.usp.br 
    Sent: Monday, April 06, 2009 7:55 PM
    Subject: Re: [Leish-l] Back to business


    Dans un e-mail daté du 04/04/2009 19:55:11 Paris, Madrid (heure d'été), killickendrick at wanadoo.fr a écrit :
      Surely Jacques is not recommending allopuriol alone as treatment? I seem to remember a study that showed this was not a good idea.
      In France, Glucantime is geverally the answer to CanL with allopurinol as well. Dogs are not destroyed by law. Medical doctors question the use of Glucantime because of the risk of drug resustance.
          By the way, 'vaccinated' dogs in Brazil are presumably seropositive. if so, they should be killed!
          Bob Killick-Kendrick
                Allopurinol alone has a great advantage , the risk of creating resistance transmitted to humans is neglectable (compared with antimonials or ampho b ) 
    Pr Slappedel   in Netherland has begun and had good results (80% long term  efficacy) . The paper you mention was published in 99  . It was a comparative study , but in  the group allopurinol alone,  dogs were only treated 1 month...  (its difficult to make a clinical studies with dogs belonging to owners) It is for me  impossible to make any conclusion from these results even if it has been done...

    In  Greece , Pr Koutinas in a 4 months study has 100% improvement and 50% of clinical cure . They have also excellent results in the most severe forms of cl (renal disease) . Gad Baneth uses also this treatment in Israel 
    In the american focus , ive treated and closely followed around 20 dogs  (Glucantime  was not available , and i didnt want to use it)  and it was a succes. The only problem is that clinical cure is reached after a longer time than with the classic association Glucantime allopurinol. But dogs dont go to work on mondays. 

    There is an emerging consensus in the vet community to avoid the use of Glucantime and amphotericin B (recent papers of the vet leish group in Trends in Parasitology)


    Regards from France 

    Jacques Lamothe


----------------------------------------------------------------------------


    _______________________________________________
    Leish-l mailing list
    Leish-l at lineu.icb.usp.br
    http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l



------------------------------------------------------------------------------


  _______________________________________________
  Leish-l mailing list
  Leish-l at lineu.icb.usp.br
  http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l
-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://lineu.icb.usp.br/pipermail/leish-l/attachments/20090407/909a0a88/attachment.htm 


More information about the Leish-l mailing list